Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants
Xiaoyan Zhang(Tongji University), Asher D. Schachter(Visterra (United States)), Susan Sloan(Visterra (United States)), Yanlin Wang(Unknown), Jill Yarbrough(Visterra (United States)), Lee Andrews(Visterra (United States)), Mohit Mathur(John Hunter Hospital), Brian J.G. Pereira(Hospital Municipal São José)
Cited by 5
Related Papers
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
|The Journal of Experimental Medicine|2003|897
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
|Nature Genetics|2006|567
Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
|Clinical Cancer Research|2017|562
Urinary N-Acetyl-β-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure
|Journal of the American Society of Nephrology|2007|509
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
|Journal of Clinical Investigation|2002|236